Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
3.150
+0.140 (4.65%)
Jan 17, 2025, 4:00 PM EST - Market closed
Neuphoria Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
24
Market Cap
11.07B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Amazon.com | 620.13B |
Apple | 391.04B |
Berkshire Hathaway | 369.89B |
Berkshire Hathaway | 369.89B |
Alphabet | 339.86B |
Alphabet | 339.86B |
Microsoft | 254.19B |
Meta Platforms | 156.23B |
NEUP News
- 4 weeks ago - Neuphoria Completes Re-domiciliation and Successor Listing on Nasdaq - GlobeNewsWire